Abstract
Objective To identify profiles of emotional and behavioral symptoms from early childhood to adolescence, their stability across development and associated factors.
Method Our sample included 17,216 children assessed at ages 3, 5, 7, 11, and 14 from the UK Millennium Cohort Study. We used latent profile and latent transition analysis to study their emotional and behavioral profiles from early childhood to adolescence. We included sociodemographic, family, and parenting variables to study the effect on the latent profile’s membership and transitions.
Results The number and specific profiles of emotional and behavioral symptoms change with the developmental stage. We found a higher number of profiles for ages 3, 5, and 14, which suggests greater heterogeneity in the presentation of emotional and behavioral symptoms for early childhood and adolescence compared to late childhood. There was greater heterotypic continuity between ages 3 and 5, particularly in transitions from higher to lower severity profiles. Children exposed to socioeconomic disadvantages were more likely to belong or transition to any moderate or high emotional and behavioral symptoms profiles. Maternal psychological distress and harsh parenting were associated with internalizing and externalizing profiles, respectively. Adolescents with high externalizing and internalizing symptoms had the greatest likelihood of reporting substance use, self-harm, and lower mental wellbeing.
Conclusion Emotional and behavioral symptoms develop early in life, with levels of heterogeneity and heterotypic stability that change throughout development. These results call for interventions for the prevention and treatment of pediatric mental illness that can account for the heterogeneity and stability of symptoms across development.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors have no funding to report.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: The authors have no funding to report.
Disclosure: Drs. Picoito, Santos, and Nunes report no biomedical financial interests or potential conflicts of interest.
Data Availability
The authors are grateful to the Centre for Longitudinal Studies (CLS), UCL Institute of Education, for the use of these data and to the UK Data Service for making them available. However, neither CLS nor the UK Data Service bear any responsibility for the analysis or interpretation of these data.
https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=2000031